- Report
- March 2024
- 200 Pages
Global
From €3845EUR$4,150USD£3,220GBP
- Report
- October 2023
- 145 Pages
Global
From €2918EUR$3,150USD£2,444GBP
- Report
- July 2023
- 145 Pages
Global
From €2918EUR$3,150USD£2,444GBP
- Report
- July 2026
- 85 Pages
France
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 85 Pages
Italy
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 62 Pages
Spain
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 90 Pages
China
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 60 Pages
Saudi Arabia
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 80 Pages
Germany
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 75 Pages
Netherlands
From €4401EUR$4,750USD£3,685GBP
- Report
- July 2026
- 90 Pages
Argentina
From €4401EUR$4,750USD£3,685GBP
- Report
- April 2026
- 90 Pages
India
From €4401EUR$4,750USD£3,685GBP
- Report
- May 2025
- 100 Pages
Global
From €4401EUR$4,750USD£3,685GBP
- Report
- February 2024
- 111 Pages
Global
From €4401EUR$4,750USD£3,685GBP
- Report
- February 2024
- 120 Pages
Global
From €4401EUR$4,750USD£3,685GBP
- Report
- February 2024
- 82 Pages
United States
From €4401EUR$4,750USD£3,685GBP
- Report
- February 2024
- 117 Pages
Global
From €4401EUR$4,750USD£3,685GBP
- Report
- November 2024
- 179 Pages
Global
From €4169EUR$4,500USD£3,491GBP
- Report
- April 2023
- 116 Pages
Global
From €4169EUR$4,500USD£3,491GBP
- Report
- July 2025
- 150 Pages
Global
From €3474EUR$3,750USD£2,909GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more